H
Harvest
Tax-loss replacement research
FTRE
Fortrea
Health CareBiotechnologyBiotechnology
28 stocks · 12 ETFs
data as of Aug 24, 2026
REPLACEMENT RESEARCH

Tax-loss harvesting alternatives for FTRE

Among the 28 Biotechnology peers screened, RGEN (Repligen) has tracked FTRE most closely over the past year, with a return correlation of 0.47. The strongest fund stand-in is ARKG (ARK Genomic Revolution ETF) at 0.48 over the past year. Correlations are computed from daily closing-price returns aligned by trading day.

Run this search live in the Screener →
STOCKS

Single-name peers

TickerNameSub-industry1Y3Y5Y10Y
RGENRepligenBiotechnology0.470.360.34
AMGNAmgen Inc.Biotechnology0.310.280.28
ARWRArrowhead PharmaceuticalsBiotechnology0.300.270.26
SRPTSarepta TherapeuticsBiotechnology0.280.230.22
INCYIncyteBiotechnology0.260.250.24
NBIXNeurocrine BiosciencesBiotechnology0.260.250.24
VIRVir Biotechnology, Inc.Biotechnology0.230.220.21
XNCRXencor IncBiotechnology0.220.310.30
BMRNBioMarin PharmaceuticalBiotechnology0.220.250.24
ADMAADMA Biologics, Inc.Biotechnology0.220.200.19
RCUSArcus Biosciences, Inc.Biotechnology0.210.250.23
TGTXTG Therapeutics, Inc.Biotechnology0.210.090.07
ROIVRoivant SciencesBiotechnology0.190.220.19
VRTXVertex PharmaceuticalsBiotechnology0.190.180.18
BIIBBiogen Inc.Biotechnology0.190.240.23
VCELVericelBiotechnology0.180.320.31
ALNYAlnylam PharmaceuticalsBiotechnology0.170.150.14
CYTKCytokineticsBiotechnology0.170.190.19
EXELExelixisBiotechnology0.160.140.13
REGNRegeneron PharmaceuticalsBiotechnology0.160.200.19
HALOHalozymeBiotechnology0.150.200.20
KRYSKrystal BiotechBiotechnology0.150.200.19
LGNDLigand Pharmaceuticals, Inc.Biotechnology0.150.210.20
MRNAModerna Inc.Biotechnology0.110.140.14
HRMYHarmony Biosciences Holdings, Inc.Biotechnology0.110.160.16
UTHRUnited TherapeuticsBiotechnology0.060.140.13
GILDGilead SciencesBiotechnology0.050.080.07
PTGXProtagonist Therapeutics, Inc.Biotechnology0.030.060.04
ETFS

Fund stand-ins

An ETF is generally not 'substantially identical' to a single stock, which is why funds are the standard wash-sale-aware replacement.

TickerNameFocusMatch1Y3Y5Y10Y
ARKGARK Genomic Revolution ETFGenomics (Active)INDUSTRY0.480.450.43
IBBiShares Biotechnology ETFBiotechnologyINDUSTRY0.380.430.42
VHTVanguard Health Care ETFHealth Care SectorSECTOR0.360.400.39
FHLCFidelity MSCI Health Care ETFHealth Care SectorSECTOR0.360.400.39
XBISPDR S&P Biotech ETFBiotechnology (Equal Wt)INDUSTRY0.350.380.37
IYHiShares US Healthcare ETFHealth Care SectorSECTOR0.340.390.38
XLVHealth Care Select Sector SPDRHealth Care SectorSECTOR0.320.360.35
IHEiShares US Pharmaceuticals ETFPharmaceuticalsINDUSTRY0.300.360.34
XPHSPDR S&P PharmaceuticalsPharmaceuticals (Equal Wt)INDUSTRY0.290.380.37
PPHVanEck Pharma ETFPharmaceuticalsINDUSTRY0.280.310.30
IHIiShares Medical Devices ETFMedical DevicesSUB-IND0.210.290.28
IHFiShares Health Care ProvidersHealth Care ProvidersINDUSTRY0.180.230.22
NEXT STEPS

Harvesting a loss in FTRE?

RELATED

Replacement research for FTRE's peers

Browse all tickers →

Method: Pearson correlation of daily closing-price returns, Yahoo Finance data, series aligned by trading day, refreshed weekly. A cell is blank when overlapping history covers less than 60% of its window. Correlation is descriptive, not predictive. Wash-sale treatment depends on facts and circumstances — confirm with a tax professional. Not investment advice.